This message was sent to ##Email##
|
|
|
|
| |
When: Thursday, Oct. 19, 2017
2–3 p.m. ET / 11 a.m.–12 p.m. PT
Speaker:
Margaret Seyffert, RN, Intensive Nursing Science Diploma, CPTC, CCTC, TPM Travel Procurement Transplant Coordinator Santa Barbara, CA
Registration Information:
$80 per webinar connection. $10 late fee applied to registrations received less than 3 days in advance.
Cancellation policy -$10 non-refundable processing fee, minimum 5 business days prior to webinar. See registration site for ideas on how to save money.
Click here to register.
Cosponsored by: the American Association of Neuroscience Nurses (AANN) and the International Transplant Nurses Society (ITNS)
The ITNS Annual Symposium Planning Committee invites you to present at the Transplant Nursing Symposium, “Transplant Nurses: Leaders in Excellence,” at the Hilton Rosemont Chicago O’Hare in Rosemont, IL from 28-30 September 2018. The submission deadline is Wednesday, 18 October 2017 by midnight (CT). Click here to submit an abstract for the Transplant Nursing Symposium in Chicago.
Help us make a difference in transplant nursing by directly supporting the valuable research and education of ITNS members who strive to improve patient care in every way. Please consider a gift to the ITNS Foundation and join us as we work to improve transplant patient care. To make a donation, you can donate online or call the ITNS member services department at +1-847-375-6340.
Liver Transplantation
In liver transplant patients with type 2 diabetes mellitus (DM), the disease worsens after transplantation because of longterm use of diabetogenic immunosuppressive drugs, making management of those patients a great challenge. The objective of our study was to evaluate the safety and efficacy of a simplified multivisceral transplantation (SMT) procedure for the treatment of patients with end-stage liver disease and concurrent type 2 DM.
READ MORE
Healio
Patients with acute-on-chronic liver failure grade 3 had similar rates of 1-year survival after liver transplantation compared with patients with a lower grade of liver failure, according to a recently published study. Researchers attributed this to quicker decision-making and better post-transplant management.
“These good survival results are associated with an increased post-LT hospital stay and high rate of complications,” Florent Artru, MD, from the Hôpital Claude Huriez, Lille, France, and colleagues wrote.
READ MORE
Chicago Tribune
Nursing school was the best," says Kathleen Donahue, a 37-year-old nurse in Springfield, and a graduate of the University of Illinois at Chicago College of Nursing. "Everything is new and exciting. You make these great friends and everything moves so fast so you never get bored."
And then?
READ MORE
American Journal of Transplantation
Cell-mediated immune responses predict clinical cytomegalovirus (CMV) events but have not been adopted into routine practice due to lack of interventional studies. Our objective was to demonstrate the safety and feasibility of early discontinuation of antivirals based on the real-time measurement of CMV-specific cell-mediated immunity (CMI) in patients with CMV viremia. Transplant patients were enrolled at the onset of CMV viremia requiring antiviral therapy.
READ MORE
Nurse.com
In late August the CDC launched Get Ahead of Sepsis, an educational campaign that emphasizes the importance of early recognition and timely treatment of sepsis, as well as the importance of preventing infections that could lead to sepsis, according to a news release.
READ MORE
News-Medical
A growing body of clinical evidence shows that transplantation of a patient's own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn's disease-related fistula can be a safe and effective addition to surgery.
READ MORE
American Journal of Transplantation
Use of eculizumab (Soliris, Alexion Pharmaceuticals), a terminal complement inhibitor, is associated with a 1000-fold to 2000-fold increased incidence of meningococcal disease [1]. Administration of meningococcal vaccines is recommended for patients receiving eculizumab before beginning treatment [2, 3]. Sixteen cases of meningococcal disease were identified in eculizumab recipients in the United States during 2008–2016; among these, 11 were caused by nongroupable Neisseria meningitidis.
READ MORE
Healio
Survival rates after liver transplantation were superior to liver resection for patients with hepatocellular carcinoma, according to results of a recently published systematic review and meta-analysis. However, overall morbidity and mortality rates and survival rate among patients with early HCC were similar.
“In practical terms, patients for whom liver resection is an option should undergo the procedure and then be evaluated for transplant in the event of a recurrence,” Markus B. Schoenberg, MD, from the University Hospital of Munich, and colleagues wrote.
READ MORE
Health Leaders Media
Ethical challenges are not left at the bedside when nurses move into leadership positions.
Chief nursing officers still experience moral distress — the disequilibrium resulting from the recognition of and inability to react ethically to a situation — it's just taboo to talk about it, finds a qualitative study published in the Journal of Nursing Administration in February 2017.
READ MORE
American Journal of Transplantation
We report the first two cases of posttransplant lymphoproliferative disorder (PTLD) in recipients of islet transplants worldwide. First, a 44-year-old recipient of three islet infusions developed PTLD 80 months after his initial transplantation, presenting with abdominal pain and diffuse terminal ileum thickening on imaging. He was treated with surgical excision, reduction of immunosuppression, and rituximab.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
